For years, scientists have been trying to see what makes a professional athlete different from someone who didn’t quite make the cut. Is there something that professional and elite athletes have that other athletes or inactive individuals don’t? Is it possible to give a mediocre athlete a supplement to improve their performance? Dr. Jonathan Schieman and George Church from the Wyss Institute at Harvard University believe the answer is yes, and they think they’ve found the answer, microbiomes.
Dr. Schieman and his team conducted thorough research on NBA players, marathoners, and Olympic rowers to see if there was a common microbiome that these high-level athletes all shared that sedentary individuals did not. After immense amounts of testing and making sure the proper controls were in place to avoid confounding, and lurking variables, Schieman and his team were able to find one particular organism that was elevated in the guts of athletes’ bodies more than sedentary individuals.
Schieman and his team were able to isolate a particularly abundant organism in athletes that feeds off lactic acid. Lactic acid is a naturally occurring chemical compound that generates during particularly intense and strenuous muscle exercise. Thus, the researchers believe that the organism they isolated has a particularly important effect on making athletes stronger. In addition, the researchers have recently conducted a new study on rugby players and found that rugby players have more of this organism in their body as well as a more diverse range of microbiomes than a sedentary individual.
The microbiome space is particularly new, so one cannot conclude that these findings will be significant to athletes in the future, a realization that Schieman has come to terms with. However, if Schieman and Church find more conclusive and concrete evidence that these, and other, organisms can yield a much better athlete, the sports world could change forever.
What do you think? Can microbiomes be used to make more elite athletes? Only time will tell.
The research is from Jonathan Schieman and George Church from the Wyss Institute at Harvard University. A comprehensive scientific journal entry has not been released to the public due to intellectual property concerns, as the findings are part of a privately-owned company.